Marc Parrish

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach

The effects of oxidative stress on female reproduction: a review

Oxidative stress, aging, and diseases

Physiological changes in pregnancy

Therapeutic plasma-exchange in hematologic disease: Results from a single center in Eastern Anatolia

Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia

Differentiation between severe HELLP syndrome and thrombotic microangiopathy, thrombotic thrombocytopenic purpura and other imitators

Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia)

Molecular and Vascular Targets in the Pathogenesis and Management of the Hypertension Associated with Preeclampsia

Effect of Silibinin in Reducing Inflammatory Pathways in In Vitro and In Vivo Models of Infection-Induced Preterm Birth

Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia

Dynamics of effector and naïve Regulatory T cells throughout pregnancy

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy

The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review)

Recombinant Vascular Endothelial Growth Factor 121 Attenuates Autoantibody-Induced Features of Pre-eclampsia in Pregnant Mice

Pre-eclampsia

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital

Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy

Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta

Early identification of women with HELLP syndrome who need plasma exchange after delivery

The renal circulation in normal pregnancy and preeclampsia: is there a place for relaxin?

An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension

Animal Models of Preeclampsia

Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

Randomized, placebo controlled, double blind trial evaluating early pregnancy phytonutrient supplementation in the prevention of preeclampsia

Agonistic Autoantibodies to the Angiotensin II Type I Receptor Cause Pathophysiologic Characteristics of Preeclampsia

Angiotensin II Type 1 Autoantibody Induced Hypertension During Pregnancy Is Associated With Renal Endothelial Dysfunction

The Effect of Immune Factors, Tumor Necrosis Factor- , and Agonistic Autoantibodies to the Angiotensin II Type I Receptor on Soluble fms-Like Tyrosine-1 and Soluble Endoglin Production in Response to Hypertension During Pregnancy

Postpartum thrombotic microangiopathic syndrome

Hypertension in Response to AT1-AA: Role of Reactive Oxygen Species in Pregnancy-Induced Hypertension

Standardized Mississippi Protocol Treatment of 190 Patients with HELLP Syndrome: Slowing Disease Progression and Preventing New Major Maternal Morbidity

Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-α

Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats